Andreas E. Kremer

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Vascular occlusion by neutrophil extracellular traps in COVID-19

Moritz Leppkes, Jasmin Knopf, Elisabeth Naschberger et al. · EBioMedicine · 2020 · 475 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +17

Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus

Andreas E. Kremer, Job J.W.W. Martens, Wim Kulik et al. · Gastroenterology · 2010 · 406 citations

Life Sciences, Biochemistry, Physiology +9

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions

Andreas E. Kremer, Remco van Dijk, Pamela Leckie et al. · Hepatology · 2012 · 290 citations · Full text

Medicine, Pathobiology, Pharmacotherapy +16

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

Gideon M. Hirschfield, Christopher L. Bowlus, Marlyn J. Mayo et al. · New England Journal of Medicine · 2024 · 235 citations

Medicine, Pharmacology, Pharmacotherapy +10